| [1] |
Oeffinger KC, Fontham ET, Etzioni R，et al. Breast cancer screening for women at average risk: 2015 guideline update from the american cancer society [J]. JAMA，2015，314(15): 1599-1614.
|
| [2] |
Rominger M, Wisgickl C, Timmesfeld N. Breast microcalcifications as type descriptors to stratify risk of malignancy: A systematic review and meta-analysis of 10665 cases with special focus on round/punctate microcalcifications [J]. Rofo，2012，184(12): 1144-1152.
|
| [3] |
Fowler EE, Sellers TA, Lu B，et al. Breast imaging reporting and data system (BI-RADS) breast composition descriptors: Automated measurement development for full field digital mammography [J]. Med Phys，2013，40(11): 113 502.
|
| [4] |
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J]. 中国癌症杂志，2019，29(8): 609-680.
|
| [5] |
Hrkac Pustahija A, Ivanac G, Brkljacic B. US and MRI in the evaluation of mammographic BI-RADS 4 and 5 microcalcifications [J]. Diagn Interv Radiol，2018，24(4): 187-194.
|
| [6] |
Sanders MA, Roland LS, Sahoo S. Clinical implications of subcategorizing BI-RADS 4 breast lesions associated with microcalcification: A radiology-pathology correlation study [J]. Breast J，2010，16(1): 28-31.
|
| [7] |
徐晓军，颜蕴文，张敬杰. 高频彩色超声结合钼靶X线摄片精确定位切除乳腺隐匿性钙化灶[J/CD]. 中华乳腺病杂志(电子版)，2012，6(5): 88-92.
|
| [8] |
郑荣寿，孙可欣，张思维，等. 2015年中国恶性肿瘤流行情况分析[J]．中华肿瘤杂志，2019，41(1): 19-28.
|
| [9] |
Sarosiek T. Systemic treatment of early breast cancer - current state of knowledge after the conference St Gallen 2017 [J]. Pol Merkur Lekarski，2017，43(257): 232-236.
|
| [10] |
DeSantis CE, Fedewa SA, Goding Sauer A，et al. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women [J]. CA Cancer J Clin，2016，66(1): 31-42.
|
| [11] |
Barreau B, de Mascarel I, Feuga C，et al. Mammography of ductal carcinoma in situ of the breast: Review of 909 cases with radiographic-pathologic correlations [J]. Eur J Radiol，2005，54(1): 55-61.
|
| [12] |
黄育北. 中国女性乳腺癌筛查指南[J]. 中国肿瘤临床，2019，46(9): 429-431.
|
| [13] |
Raza S, Vallejo M, Chikarmane SA，et al. Pure ductal carcinoma in situ: A range of mri features [J]. AJR Am J Roentgenol，2008，191(3): 689-699.
|
| [14] |
Eun NL, Son EJ, Gweon HM，et al. The value of breast mri for BI-RADS category 4B mammographic microcalcification: Based on the 5(th) edition of bi-rads [J]. Clin Radiol，2018，73(8): 750-755.
|
| [15] |
Kuhl CK, Schrading S, Bieling HB，et al. MRI for diagnosis of pure ductal carcinoma in situ: A prospective observational study [J]. Lancet，2007，370(9586): 485-492.
|
| [16] |
Hartmann LC, Sellers TA, Frost MH，et al. Benign breast disease and the risk of breast cancer [J]. N Engl J Med，2005，353(3): 229-237.
|
| [17] |
Wang Y, Gao Y, Battsend M，et al. Development of a risk assessment tool for projecting individualized probabilities of developing breast cancer for chinese women [J]. Tumour Biol，2014，35(11): 10 861-10 869.
|
| [18] |
Ahmadiyeh N, Stoleru MA, Raza S，et al. Management of intraductal papillomas of the breast: An analysis of 129 cases and their outcome [J]. Ann Surg Oncol，2009，16(8): 2264-2269.
|
| [19] |
Hodorowicz-Zaniewska D, Szpor J, Basta P. Intraductal papilloma of the breast - management [J]. Ginekol Pol，2019，90(2): 100-103.
|
| [20] |
Vachon CM, Pankratz VS, Scott CG，et al. The contributions of breast density and common genetic variation to breast cancer risk [J]. J Natl Cancer Inst，2015，107(5): dju397.
|
| [21] |
Worsham MJ, Raju U, Lu M，et al. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer [J]. Clin Cancer Res，2007，13(18 Pt 1): 5474-5479.
|
| [22] |
Rosen EL, Smith-Foley SA, DeMartini WB，et al. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ [J]. Breast J，2007，13(6): 545-550.
|
| [23] |
van Seijen M, Lips EH, Thompson AM，et al. Ductal carcinoma in situ: to treat or not to treat, that is the question [J]. Br J Cancer，2019，121(4): 285-292.
|